| abstract |
TANAPROGET POLYMORPHIC FORM II, PROCESSES FOR PREPARING THEM, AND FOR PREPARING MICROMIZED FORM OF A COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION, AND, USE OF THE TIMAPORM FORMULAR FORM II. Tanaproget polymorphic Form II, processes for the preparation of tanaproget Polymorphic Form II, pharmaceutical compositions including tanaproget Polymorphic Form II, micronized tanaproget Polymorphic Form II, and processes for converting Form II to Form 1 are provided. Methods of contraception, hormone replacement therapy, stimulation of food intake and treatment or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovarian syndrome, or carcinomas are also provided. adenocarcinomas comprising administering polymorph Form II to a mammalian patient. |